These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hyperthemia enhances activated lymphocytes and molecular target therapy]. Takeda T; Hasegawa T; Miyazawa K; Yoshida K; Takeda T; Takeda H; Takahashi T; Yamamoto I; Kobayashi S Gan To Kagaku Ryoho; 2011 Nov; 38(12):1924-6. PubMed ID: 22202240 [TBL] [Abstract][Full Text] [Related]
3. [Successful immunotherapy combined with hyperthermia therapy for cancer patients]. Takeda T; Dong X; Takeda H; Haba A; Takeda Y Gan To Kagaku Ryoho; 2006 Nov; 33(12):1739-41. PubMed ID: 17212092 [TBL] [Abstract][Full Text] [Related]
4. [Multidisciplinary therapy for 984 cancer patients--hyperthermic immunotherapy]. Takeda T; Miyazawa K; Takeda T; Takeda H; Takeda Y Gan To Kagaku Ryoho; 2010 Nov; 37(12):2243-5. PubMed ID: 21224535 [TBL] [Abstract][Full Text] [Related]
5. [Hyperthermic immunotherapy was effective in 3 CR cases as the standard treatments had no effects or could not be enforced]. Takeda H; Takeda T; Kobayashi S; Takeda T Gan To Kagaku Ryoho; 2011 Nov; 38(12):1939-41. PubMed ID: 22202245 [TBL] [Abstract][Full Text] [Related]
6. [The effect of immunotherapy and hyperthermia on patients with advanced or recurrent cancer - analyses by cancer type and recurrence form]. Takeda T; Nakamura K; Sato M; Takeda T; Tomimaru Y; Takeda H Gan To Kagaku Ryoho; 2014 Oct; 41(10):1261-3. PubMed ID: 25335711 [TBL] [Abstract][Full Text] [Related]
7. [The effect of immunotherapy and hyperthermia on advanced or recurrent ovarian and uterine cancer - 229 clinical cases]. Nakamura K; Hanazawa S; Takeda T; Sumiyoshi R; Kobayashi S; Takeda H; Takeda T Gan To Kagaku Ryoho; 2014 Oct; 41(10):1295-7. PubMed ID: 25335722 [TBL] [Abstract][Full Text] [Related]
8. [The effect of immunotherapy and hyperthermia for advanced or recurrent head and neck cancer - 74 clinical cases]. Takeda T; Takeda H; Tanaka C; Maruhashi S; Takeda T Gan To Kagaku Ryoho; 2014 Oct; 41(10):1283-5. PubMed ID: 25335718 [TBL] [Abstract][Full Text] [Related]
9. [Mechanism of immunotherapy enhancement in cancer therapy by hyperthermia]. Takeda T; Miyazawa K; Takeda T; Takeda H; Hasegawa T; Takeda Y Gan To Kagaku Ryoho; 2009 Nov; 36(12):1955-7. PubMed ID: 20037289 [TBL] [Abstract][Full Text] [Related]
10. [The effect of immunotherapy and hyperthermia on patients with advanced or recurrent breast cancer]. Takeda T; Takeda T; Etani M; Kobayashi S; Takeda H Gan To Kagaku Ryoho; 2013 Nov; 40(12):1596-9. PubMed ID: 24393860 [TBL] [Abstract][Full Text] [Related]
11. Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma. Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H J Biosci Bioeng; 2005 Jul; 100(1):112-5. PubMed ID: 16233860 [TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy and hyperthermia for the treatment of patients with advanced or recurrent colorectal cancer]. Takeda T; Akita H; Takeda T; Nakamura K; Kobayashi S; Takeda H Gan To Kagaku Ryoho; 2013 Nov; 40(12):1606-8. PubMed ID: 24393863 [TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy with hyperthermia for advanced or recurrent breast cancer patients in whom standard therapy showed no effect or was refused]. Takeda T; Takeda T; Kobayashi S; Takeda H Gan To Kagaku Ryoho; 2012 Nov; 39(12):1766-9. PubMed ID: 23267880 [TBL] [Abstract][Full Text] [Related]
14. [Effects of intratumoral injection therapy of dendritic cells combined with hyperthermia for cancer patients]. Takeda T; Dong X; Takeda H; Haba A; Takeda Y Gan To Kagaku Ryoho; 2007 Nov; 34(12):1905-7. PubMed ID: 18219848 [TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells. Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952 [TBL] [Abstract][Full Text] [Related]
16. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges. Shen RN; Lu L; Kaiser HE; Broxmeyer HE In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711 [TBL] [Abstract][Full Text] [Related]
17. New insight into hyperthermic intraperitoneal chemotherapy: induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models. Lehmann K; Rickenbacher A; Jang JH; Oberkofler CE; Vonlanthen R; von Boehmer L; Humar B; Graf R; Gertsch P; Clavien PA Ann Surg; 2012 Nov; 256(5):730-7; discussion 737-8. PubMed ID: 23095616 [TBL] [Abstract][Full Text] [Related]
18. [Augmentation of therapeutic effect of adoptive immunotherapy through a synergy between transferred killer cells and host's fresh lymphocytes]. Kan N; Yamasaki S; Harada T; Satoh K; Ichinose Y; Moriguchi Y; Kodama H; Ohgaki K Hum Cell; 1992 Sep; 5(3):236-42. PubMed ID: 1467322 [TBL] [Abstract][Full Text] [Related]
19. Modulated electro-hyperthermia enhances dendritic cell therapy through an abscopal effect in mice. Qin W; Akutsu Y; Andocs G; Suganami A; Hu X; Yusup G; Komatsu-Akimoto A; Hoshino I; Hanari N; Mori M; Isozaki Y; Akanuma N; Tamura Y; Matsubara H Oncol Rep; 2014 Dec; 32(6):2373-9. PubMed ID: 25242303 [TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of the combined use of radiation therapy and hyperthermia]. Matsuda T; Tanaka Y; Takeshita N; Ishiwata J; Awane Y Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1508-14. PubMed ID: 3592696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]